Journal article
Abstract 14299: The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial
Abstract
Introduction:
Heart failure with preserved ejection fraction (HFpEF) is associated with considerable morbidity and mortality. Insulin-like growth factor-binding protein 7 (IGFBP7) is a cell cycle arrest biomarker associated with abnormal diastology and prognosis in HF with reduced EF (HFrEF). Its role in patients with HFpEF is unknown.
Authors
Gandhi PU; Chow SL; Rector TS; Krum H; Gaggin HK; McMurray JJ; Zile M; Komajda M; McKelvie RS; Carson PE
Journal
Circulation, Vol. 132, No. suppl_3,
Publisher
Wolters Kluwer
Publication Date
November 10, 2015
DOI
10.1161/circ.132.suppl_3.14299
ISSN
0009-7322